![Claire S. Padgett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Claire S.
Padgett formerly worked at Conforma Therapeutics Corp., as Executive Director-Clinical Operations, Oncolytics Biotech, Inc., as Vice President-Clinical Operations, Cylene Pharmaceuticals, Inc., as Vice President-Clinical Operations, Mirati Therapeutics, Inc., as Senior Vice President-Clinical Operations from 2017 to 2018, Regulus Therapeutics, Inc., as Senior Vice President-Clinical Operations from 2022 to 2025, and Mast Therapeutics, Inc., as Vice President-Clinical Operations from 2012 to 2018.
Dr. Padgett received her undergraduate degree from Rutgers State University of New Jersey, graduate degree and Masters Business Admin degree from Seton Hall University, and doctorate degree from Capella University LLC.
Anciens postes connus de Claire S. Padgett
| Sociétés | Poste | Fin |
|---|---|---|
| REGULUS THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 01/12/2025 |
| MIRATI THERAPEUTICS | Corporate Officer/Principal | 01/10/2018 |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Directeur Technique/Scientifique/R&D | 01/10/2018 |
Cylene Pharmaceuticals, Inc.
 Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small molecule drugs | Directeur des opérations | 28/09/2010 |
| ONCOLYTICS BIOTECH INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Claire S. Padgett
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
24
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Health Technology |
Oncolytics Biotech, Inc.
 Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small molecule drugs | Health Technology |
Conforma Therapeutics Corp.
 Conforma Therapeutics Corp. BiotechnologyHealth Technology Designs and develops drugs for treatment of cancer | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seton Hall University
 Seton Hall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Capella University LLC
 Capella University LLC Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Regulus Therapeutics, Inc.
 Regulus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering and developing of drugs | Health Technology |
